Streetbeat News

Corporate Responsibility

BGNE

The Max Foundation, BeiGene, and the BeiGene Foundation have initiated the distribution of BRUKINSA, a treatment for Chronic Lymphocytic Leukemia, to patients in low- and middle-income countries, starting with Armenia and Nepal. This effort is part of a collaboration aimed at improving access to this critical medication in 29 countries.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 12:08 pm

CPRX

Catalyst Pharmaceuticals announced the U.S. commercial launch of AGAMREE for Duchenne Muscular Dystrophy (DMD) treatment in patients aged two and older. AGAMREE, approved by the FDA on October 26, 2023, is now available by prescription. It offers a novel alternative to current steroid treatments, potentially reducing side effects and improving quality of life for DMD patients. Catalyst's Pathways Program supports patient access and education. AGAMREE has shown comparable efficacy to standard corticosteroids with a better side effect profile in clinical trials.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 12:01 pm

GOOGL

Google has implemented restrictions on its AI chatbot, Gemini, to limit responses to election-related queries, aiming to prevent misinformation. This move is part of Google's election integrity strategy, especially relevant as India approaches its elections. The restrictions are already in effect in India, where Gemini directs users to Google Search for questions about elections in the U.S., U.K., and South Africa, but still answers queries on Indian politics. This decision aligns with global concerns over AI's role in spreading election misinformation and follows regulatory actions in India requiring tech companies to seek approval before deploying certain AI tools.

Portfolio Pulse from Benzinga Neuro

March 13, 2024 | 12:01 pm

AGRX

Agile Therapeutics has fully repaid its debt facility with Perceptive Advisors, focusing on expanding Twirla and advancing its business plan.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:42 am

ARCO

Arcos Dorados announced plans to open 80 to 90 new restaurants in 2024, with approximately 90% being free-standing units. The company anticipates total capital expenditures for 2024 to be between $300M and $350M.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:36 am

HSBC

HSBC has announced the appointment of Andrew Fullam as the new Chief Financial Officer (CFO) for the US and Americas. This strategic move aims to strengthen HSBC's financial leadership and operational efficiency in these key markets.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:32 am

TSLA

Tesla shareholders, upset with the Delaware Court's nullification of CEO Elon Musk's 2018 compensation package worth $56 billion, attempted to influence the court through letters and are now considering a floral tribute to shareholder rights. The court's decision, seen as unfair by some shareholders, led to a unique form of protest supported by Musk himself.

Portfolio Pulse from Anan Ashraf

March 13, 2024 | 11:27 am

WOOF

Petco Health and Wellness has announced the appointment of R. Michael (Mike) Mohan as the interim Chief Executive Officer, effective immediately. This leadership change could signal a new strategic direction or stabilization efforts by the company.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:15 am

MSFT

TSLA

Elon Musk, CEO of Tesla Inc, mocked OpenAI's logo on X, suggesting it spells 'LIE', which led to backlash from users who criticized Tesla's Full Self Driving feature. Musk's contentious relationship with OpenAI, a company he co-founded and left, has been highlighted by a lawsuit he filed against them, accusing them of betraying founding principles. OpenAI, supported by Microsoft Corporation, refuted Musk's claims, stating there's no founding agreement as Musk suggested.

Portfolio Pulse from Ananya Gairola

March 13, 2024 | 11:14 am

HCM

MXCT

SIGA

SKIN

Beauty Health reported better-than-expected Q4 revenue, leading to a 17.3% pre-market stock increase. Other stocks like HUTCHMED, SIGA Technologies, BeiGene, MaxCyte, Full Truck Alliance, Legend Biotech, Clover Health, and United Natural Foods also saw pre-market gains following positive financial results, analyst ratings, and corporate announcements.

Portfolio Pulse from Avi Kapoor

March 13, 2024 | 10:16 am